_version_ 1867005699382312960
author Marika Milan
Fabio Maiullari
Maila Chirivì
Maria Grazia Ceraolo
Rebecca Zigiotto
Andrea Soluri
Silvia Maiullari
Elisa Landoni
Dario Di Silvestre
Francesca Brambilla
Pierluigi Mauri
Veronica De Paolis
Nicole Fratini
Maria Cristina Crosti
Chiara Cordiglieri
Chiara Parisi
Antonella Calogero
Dror Seliktar
Yvan Torrente
Chiara Lanzuolo
Gianpietro Dotti
Mirco Toccafondi
Mauro Bombaci
Elena De Falco
Claudia Bearzi
Roberto Rizzi
author_facet Marika Milan
Fabio Maiullari
Maila Chirivì
Maria Grazia Ceraolo
Rebecca Zigiotto
Andrea Soluri
Silvia Maiullari
Elisa Landoni
Dario Di Silvestre
Francesca Brambilla
Pierluigi Mauri
Veronica De Paolis
Nicole Fratini
Maria Cristina Crosti
Chiara Cordiglieri
Chiara Parisi
Antonella Calogero
Dror Seliktar
Yvan Torrente
Chiara Lanzuolo
Gianpietro Dotti
Mirco Toccafondi
Mauro Bombaci
Elena De Falco
Claudia Bearzi
Roberto Rizzi
Marika Milan
Fabio Maiullari
Maila Chirivì
Maria Grazia Ceraolo
Rebecca Zigiotto
Andrea Soluri
Silvia Maiullari
Elisa Landoni
Dario Di Silvestre
Francesca Brambilla
Pierluigi Mauri
Veronica De Paolis
Nicole Fratini
Maria Cristina Crosti
Chiara Cordiglieri
Chiara Parisi
Antonella Calogero
Dror Seliktar
Yvan Torrente
Chiara Lanzuolo
Gianpietro Dotti
Mirco Toccafondi
Mauro Bombaci
Elena De Falco
Claudia Bearzi
Roberto Rizzi
collection Wiley Open Access
contents Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy Marika Milan Fabio Maiullari Maila Chirivì Maria Grazia Ceraolo Rebecca Zigiotto Andrea Soluri Silvia Maiullari Elisa Landoni Dario Di Silvestre Francesca Brambilla Pierluigi Mauri Veronica De Paolis Nicole Fratini Maria Cristina Crosti Chiara Cordiglieri Chiara Parisi Antonella Calogero Dror Seliktar Yvan Torrente Chiara Lanzuolo Gianpietro Dotti Mirco Toccafondi Mauro Bombaci Elena De Falco Claudia Bearzi Roberto Rizzi The Journal of Pathology Abstract Duchenne muscular dystrophy (DMD) is caused by the absence of the full form of the dystrophin protein, which is essential for maintaining the structural integrity of muscle cells, including those in the heart and respiratory system. Despite progress in understanding the molecular mechanisms associated with DMD, myocardial insufficiency persists as the primary cause of mortality, and existing therapeutic strategies remain limited. This study investigates the hypothesis that a dysregulation of the biological communication between infiltrating macrophages (MPs) and neurocardiac junctions exists in dystrophic cardiac tissue. In a mouse model of DMD ( mdx ), this phenomenon is influenced by the over‐release of chondroitin sulfate proteoglycan‐4 (CSPG4), a key inhibitor of nerve sprouting and a modulator of the neural function, by MPs infiltrating the cardiac tissue and associated with dilated cardiomyopathy, a hallmark of DMD. Givinostat, the histone deacetylase inhibitor under current development as a clinical treatment for DMD, is effective at both restoring a physiological microenvironment at the neuro‐cardiac junction and cardiac function in mdx mice in addition to a reduction in cardiac fibrosis, MP‐mediated inflammation, and tissue CSPG4 content. This study provides novel insight into the pathophysiology of DMD in the heart, identifying potential new biological targets. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6362 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1002/path.6362
format Artículo Open Access
id wiley_oa_10_1002_path_6362
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy
Marika Milan
Fabio Maiullari
Maila Chirivì
Maria Grazia Ceraolo
Rebecca Zigiotto
Andrea Soluri
Silvia Maiullari
Elisa Landoni
Dario Di Silvestre
Francesca Brambilla
Pierluigi Mauri
Veronica De Paolis
Nicole Fratini
Maria Cristina Crosti
Chiara Cordiglieri
Chiara Parisi
Antonella Calogero
Dror Seliktar
Yvan Torrente
Chiara Lanzuolo
Gianpietro Dotti
Mirco Toccafondi
Mauro Bombaci
Elena De Falco
Claudia Bearzi
Roberto Rizzi
The Journal of Pathology
Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy Marika Milan Fabio Maiullari Maila Chirivì Maria Grazia Ceraolo Rebecca Zigiotto Andrea Soluri Silvia Maiullari Elisa Landoni Dario Di Silvestre Francesca Brambilla Pierluigi Mauri Veronica De Paolis Nicole Fratini Maria Cristina Crosti Chiara Cordiglieri Chiara Parisi Antonella Calogero Dror Seliktar Yvan Torrente Chiara Lanzuolo Gianpietro Dotti Mirco Toccafondi Mauro Bombaci Elena De Falco Claudia Bearzi Roberto Rizzi The Journal of Pathology Abstract Duchenne muscular dystrophy (DMD) is caused by the absence of the full form of the dystrophin protein, which is essential for maintaining the structural integrity of muscle cells, including those in the heart and respiratory system. Despite progress in understanding the molecular mechanisms associated with DMD, myocardial insufficiency persists as the primary cause of mortality, and existing therapeutic strategies remain limited. This study investigates the hypothesis that a dysregulation of the biological communication between infiltrating macrophages (MPs) and neurocardiac junctions exists in dystrophic cardiac tissue. In a mouse model of DMD ( mdx ), this phenomenon is influenced by the over‐release of chondroitin sulfate proteoglycan‐4 (CSPG4), a key inhibitor of nerve sprouting and a modulator of the neural function, by MPs infiltrating the cardiac tissue and associated with dilated cardiomyopathy, a hallmark of DMD. Givinostat, the histone deacetylase inhibitor under current development as a clinical treatment for DMD, is effective at both restoring a physiological microenvironment at the neuro‐cardiac junction and cardiac function in mdx mice in addition to a reduction in cardiac fibrosis, MP‐mediated inflammation, and tissue CSPG4 content. This study provides novel insight into the pathophysiology of DMD in the heart, identifying potential new biological targets. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6362 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Macrophages producing chondroitin sulfate proteoglycan‐4 induce neuro‐cardiac junction impairment in Duchenne muscular dystrophy
topic The Journal of Pathology
url https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6362